Indian Journal of Nephrology Home 

ORIGINAL ARTICLE
[View FULLTEXT] [Download PDF]
Year : 2022  |  Volume : 32  |  Issue : 2  |  Page : 110--115

Single-center haemodialysis experience in India during COVID-19

Himansu Sekhar Mahapatra, Muthukumar Balakrishnan, Lalit Purusunani, Adarsh Kumar, Renju Binoy, Mansi Singh, Abhisek Gautam, Neeraj Inamdar 
 Department of Nephrology, Atal Bihari Institute of Medical Sciences, Dr. Ram Manohar Lohia Hospital, New Delhi, India

Correspondence Address:
Neeraj Inamdar
Department of Nephrology, ABVIMS, Dr. Ram Manohar Lohia Hospital, New Delhi
India

Introduction: Since COVID-19 has been announced as a pandemic, outcome of dialysis patients in terms of morbidity and mortality from India is lacking. We studied the clinical, epidemiological features of COVID-19 along with outcome in terms of mortality in our dialysis cohort. Methods: Data of End-Stage Kidney Disease (ESKD) patients who were admitted in COVID-19 designated hospital block as positive and suspected patients from 1st April 2020 to 31st July 2020 was retrieved. Data about epidemiological characteristics, clinical features, mortality outcomes of COVID-19 positive and negative patients were analyzed. Results: A total of 97 ESKD patients were admitted during the study period, of which 44 (45.4%) and 53 (54.6%) patients were found to be COVID-19 positive and negative respectively. The mean age of COVID positive patients was 46 years with 54.5% being female. Only three patients (6.8%) remained asymptomatic throughout the course of illness. Amongst COVID-19 positive, 20 (45.45%) were severely ill while 18 (40.9%) were having mild illnesses. Breathlessness (65.9%) and fever (61.4%) were common symptoms. The death occurred in 17 (38.6%) and 25 (47.1%) COVID-19 positive and negative ESKD patients respectively. 14 (82.3%) patients who expired amongst COVID-19 positive were having severe illness and significantly more were associated with negligible residual renal function. Conclusions: Breathlessness and fever were common symptoms amongst COVID-19 ESKD patients. Very few patients remained asymptomatic in our cohort and significantly more mortality is observed in severely ill patients and those with negligible residual renal function.

How to cite this article:
Mahapatra HS, Balakrishnan M, Purusunani L, Kumar A, Binoy R, Singh M, Gautam A, Inamdar N. Single-center haemodialysis experience in India during COVID-19.Indian J Nephrol 2022;32:110-115

How to cite this URL:
Mahapatra HS, Balakrishnan M, Purusunani L, Kumar A, Binoy R, Singh M, Gautam A, Inamdar N. Single-center haemodialysis experience in India during COVID-19. Indian J Nephrol [serial online] 2022 [cited 2022 May 16 ];32:110-115
Available from: https://www.indianjnephrol.org/article.asp?issn=0971-4065;year=2022;volume=32;issue=2;spage=110;epage=115;aulast=Mahapatra;type=0